Table 3.
Comparison of PPCT and SFCT Between CRVO and BRVO
CRVO n=26 | BRVO n=45 | P | |
---|---|---|---|
PPCT | |||
Affected-eye (µm) | |||
Baseline | 155.38±48.23 | 116.84±51.30 | 0.017* |
3 months | 132.34±52.64 | 114.52±52.34 | 0.408 |
9 months | 151.84±61.61 | 113.17±53.76 | 0.017* |
Fellow-eye (µm) | |||
Baseline | 144.50±59.71 | 106.77±48.03 | 0.014* |
3 months | 136.72±58.37 | 113.00±50.88 | 0.192 |
9 months | 162.13±59.85 | 109.69±50.43 | 0.001* |
SFCT | |||
Affected-eye (µm) | |||
Baseline | 273.16±60.99 | 232.00±77.49 | 0.129 |
3 months | 251.65±74.50 | 220.62±77.51 | 0.402 |
9 months | 246.47±69.45 | 222.93±82.17 | 0.073 |
Fellow-eye (µm) | |||
Baseline | 248.05±82.80 | 205.62±82.41 | 0.099 |
3 months | 236.39±86.23 | 213.70±67.67 | 0.405 |
9 months | 259.75±85.09 | 201.74±84.86 | 0.011* |
Notes: Comparisons between CRVO and BRVO evaluated through ANCOVA (values presented were corrected for age). *p <0.05: statistically significant.
Abbreviations: CRVO, central retinal vein occlusion; BRVO, branch retinal vein occlusion; PPCT, peripapillary choroidal thickness; SFCT, subfoveal choroidal thickness.